Projects per year
Personal profile
Education
- 2010 PhD, Institute of Clinical Pharnacy and Pharmaceutical Sciences, National Cheng Kung University
Experience
- 20017/1-present Vice Director, Department of Pharmacy, National Cheng Kung University Hospital
- 2012/8~present Assistant professor, School of Pharmacy, National Cheng Kung University
Research Interests
- Clinical pharmacy
- Parmacoepidemiology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Ching-Lan Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 5 Finished
-
-
-
全球抗生素之抗藥性、處方型態及療效於新生兒及孩童多國聯合資訊-建立台灣前導模式
Cheng, C.-L. (PI)
16-08-01 → 17-07-31
Project: Research project
-
-
-
An interpretable machine learning approach to evaluate 30-day mortality risk in patients with community-onset bacteremia
Su, C. C., Chen, J.-L., Lee, C. C., Li, C. T., Lin, W. L. & Cheng, C. L., 2025, (Accepted/In press) In: Journal of Microbiology, Immunology and Infection.Research output: Contribution to journal › Article › peer-review
Open Access -
Epidemiology and Steroid Dependency Reduction in Crohn’s Disease During the Biologics Era: A Nationwide Population-Based Study
Chen, N. Y., Chuang, C. H., Chang, Y. C., Kao Yang, Y. H., Hsu, H., Chen, C. M. & Cheng, C. L., 2025 Sept, In: Advances in Therapy. 42, 9, p. 4318-4334 17 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Accelerated risk of renal disease progression in pre-ESRD patients with proton pump inhibitors use: a nationwide population-based study
Huang, C. H., Tsai, C. J., Su, C. C., Yen, C. T., Chen, J. L. & Cheng, C. L., 2024 Dec, In: BMC Nephrology. 25, 1, 469.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients
Huang, C. H., Tseng, Y. H., Tsai, W. S., Su, C. C., Cheng, C. L., Kao Yang, Y. H., Chang, Y. C. & Liu, Y. H., 2024 Feb, In: Infectious Diseases and Therapy. 13, 2, p. 373-383 11 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Hospitalized patients on proton pump inhibitors for stress ulcer prophylaxis have a higher risk of Clostridioides difficile infection compared with those on histamine-2 receptor antagonists
Wu, L. H., Wang, J. L., Liu, Y. H., Su, C. C., Yang, Y. H. K., Lin, S. J. & Cheng, C. L., 2024 Dec, In: Journal of Hospital Infection. 154, p. 9-17 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)